Sangani Hospitals logo

Sangani Hospitals MD, chairman, board of directors and AGM

NSE: SANGANIHealthcare Services

Last close ₹59.70₹0.00 (0.00%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹59.70.

52-week range of traded prices to 23 Oct 2026
₹37.00Low, 1 Apr 2026₹70.35High, 18 Nov 2025
Market cap
₹82 Cr
P/E
27.5
P/B
2.0
Dividend yield
Nonein the last 12 months
ROE
7.8%
Debt to equity
0.04
Volume, NSE
1,500100.0% delivered

Sangani Hospitals board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

    An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

    Statutory auditor

    Named in the results for the quarter to Mar 2026.

    • R G G R & ASSOCIATESPeer-review certificate valid to Jan 2028
    1 earlier auditor
    • KUMBHAT & COMPANYNamed in the filing for the quarter to Mar 2025

    A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

    Sangani Hospitals AGM and shareholder votes

    Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sangani Hospitals share news and announcements

    Annual general meeting, 28 Sep 2026

    453 shareholders on the register on 28 Aug 2026; present: 7 promoters and 4 others; votes counted by KEYUR GHELANI / K P GHELANI & ASSOCIATES.The company's voting result (opens in a new tab)

    1. To receive, consider and adopt the Consolidated and standalone Audited Financial Statements for the financial year ended March 31, 2026 and the Reports of Directors’ and Auditors’ thereon.
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 72.86% · promoters 98.22% · institutions 0.00% · other public 0.34%

    2. To appoint a director in place of Mr. Rajeshkumar Sangani (DIN- 09394928) who retires by rotation, and being eligible, offers himself for re-appointment.
      OrdinaryPromoters have an interest in it
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 72.86% · promoters 98.22% · institutions 0.00% · other public 0.34%

    3. Appointment of Statutory Auditors for a term of five consecutive years
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 72.86% · promoters 98.22% · institutions 0.00% · other public 0.34%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Investor complaints and compliance

    Quarter by quarter.

    Investor complaints received and resolved, the company's own count

    • Received
    • Resolved

    Open at the quarter's end

    None open at any quarter's end.
    The filing has a part on fines and penalties
    No
    The filing has a part on tax disputes
    No

    The company's own answers in its filing.

    How money raised was used

    Reported for the quarter to Sep 2025. The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it.

    RaisedAmount raisedForSet asideSpentSpent elsewhereSpent elsewhere, amount
    Public IssuesAug 202315.17Acquisition of 55% Equity Share Capital of Sadbhavna Hospital and Medical Research Centre Private Limited5.375.37Yes5.37
    Public IssuesAug 202315.17Acquisition of 55% Equity Share Capital of Sadbhavna Hospital and Medical Research Centre Private Limited2.642.64Yes2.64
    Public IssuesAug 202315.17Acquisition of 55% Equity Share Capital of Sadbhavna Hospital and Medical Research Centre Private Limited0.090.09Yes0.09
    Public IssuesAug 202315.17Issue Expenses2.270.00Yes
    ₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.